{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:27:48Z","timestamp":1794670068885,"version":"4.9.1"},"reference-count":29,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,25]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Newer approaches to control alloreactivity may produce similar transplant outcomes using HLA-mismatched donors vs HLA-matched unrelated donors (MUD). However, prospective comparisons are lacking. BMT CTN 1702 used a donor search prognosis score to assign patients to an 8\/8 HLA MUD or the center\u2019s preference of haploidentical related donors (HAPLO), mismatched unrelated donors (MMUD), or umbilical cord blood (UCB). Outcomes of MUD were compared to HAPLO, MMUD, and UCB transplantation after adjusting for covariates. Patients (n = 1179 [93% adults]) underwent transplantation with MUD (n = 772), HAPLO (n = 254), MMUD (n = 112), and UCB (n = 41) at a median of 3.7, 3.4, 3.9, and 3.8 months from enrollment. Posttransplant cyclophosphamide (PTCy) was used in 23.9%, 83.9%, 65.2%, and 0% of MUD, HAPLO, MMUD, and UCB. In multivariate analyses, compared to MUD, survival was lower for UCB (hazard ratio [HR], 2.65; P&amp;lt; .001) but not statistically different for HAPLO and MMUD (HRs, 1.08 and 1.18, respectively). Relapse risk was not significantly different by donor, but treatment-related mortality (HR, 3.31; P&amp;lt; .001) and disease-free survival (HR, 1.99; P = .002) were inferior for UCB but not different for HAPLO and MMUD than MUD. In patients who received PTCy, HAPLO and MMUD were associated with increased grade 3 or 4 acute graft-versus-host disease (GVHD; HR, 2.39 [P = .017] and 2.53 [P = .038], respectively) and chronic GVHD (HR, 1.71 for both; P = .028 and .080) than MUD, but other outcomes were not different. HAPLO or MMUD may be used to expedite transplantation when finding MUD is unlikely. This study was registered at www.clinicaltrials.gov as NCT03904134.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026020355","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:17:06Z","timestamp":1781043426000},"page":"5543-5552","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Donor-specific transplant outcomes from BMT CTN 1702: a multicenter prospective biologic assignment trial"],"prefix":"10.1182","volume":"10","author":[{"given":"Asad","family":"Bashey","sequence":"first","affiliation":[{"name":"1Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Logan","sequence":"additional","affiliation":[{"name":"2Data Science Institute, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4304-935X","authenticated-orcid":false,"given":"LaQuisa","family":"Hill","sequence":"additional","affiliation":[{"name":"3Division of Hematology Oncology, Center for Gene Therapy, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Symons","sequence":"additional","affiliation":[{"name":"4Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosha","family":"Farhadfar","sequence":"additional","affiliation":[{"name":"5Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5407-9875","authenticated-orcid":false,"given":"Michael R.","family":"Grunwald","sequence":"additional","affiliation":[{"name":"6Levine Cancer Institute, Atrium Health, Charlotte, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pidala","sequence":"additional","affiliation":[{"name":"7H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7469-314X","authenticated-orcid":false,"given":"Jason G.","family":"Dehn","sequence":"additional","affiliation":[{"name":"8National Marrow Donor Program, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1997-3799","authenticated-orcid":false,"given":"Claudio","family":"Brunstein","sequence":"additional","affiliation":[{"name":"9Department of Hematology Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1993-4172","authenticated-orcid":false,"given":"Sally","family":"Arai","sequence":"additional","affiliation":[{"name":"10Blood and Marrow Transplant Program, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leifer","sequence":"additional","affiliation":[{"name":"11The National Heart, Lung, and Blood Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naya","family":"He","sequence":"additional","affiliation":[{"name":"12Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwen E.","family":"Shaw","sequence":"additional","affiliation":[{"name":"12Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2074-5678","authenticated-orcid":false,"given":"Mark","family":"Juckett","sequence":"additional","affiliation":[{"name":"13Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7731-759X","authenticated-orcid":false,"given":"Steven","family":"Devine","sequence":"additional","affiliation":[{"name":"8National Marrow Donor Program, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Uberti","sequence":"additional","affiliation":[{"name":"14Karmanos Cancer Institute, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Westervelt","sequence":"additional","affiliation":[{"name":"15MaineHealth Cancer Care, Scarborough, ME"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer A.","family":"Srour","sequence":"additional","affiliation":[{"name":"16Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1725-5184","authenticated-orcid":false,"given":"Iskra","family":"Pusic","sequence":"additional","affiliation":[{"name":"17Division of Oncology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumithira","family":"Vasu","sequence":"additional","affiliation":[{"name":"18Department of Blood and Marrow Transplant and Cell Therapy, The Ohio State University, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-4573","authenticated-orcid":false,"given":"Brandon","family":"Hayes-Lattin","sequence":"additional","affiliation":[{"name":"19Oregon Health Sciences University Knight Cancer Institute, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-3271","authenticated-orcid":false,"given":"Stefan O.","family":"Ciurea","sequence":"additional","affiliation":[{"name":"20Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, University of California, Irvine, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Horowitz","sequence":"additional","affiliation":[{"name":"2Data Science Institute, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-6390","authenticated-orcid":false,"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[{"name":"21Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5841-4105","authenticated-orcid":false,"given":"William J.","family":"Hogan","sequence":"additional","affiliation":[{"name":"22Department of Hematology and Transplant Center, Mayo Clinic Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"4","key":"2026082510524527100_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"28","key":"2026082510524527100_bib2","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1200\/JCO.24.00582","article-title":"Human leukocyte antigen mismatching and survival in contemporary hematopoietic cell transplantation for hematologic malignancies","volume":"42","author":"Arrieta-Bolanos","year":"2024","journal-title":"J Clin Oncol"},{"issue":"12","key":"2026082510524527100_bib3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"issue":"7","key":"2026082510524527100_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41409-023-01980-y","article-title":"Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP\/EBMT","volume":"58","author":"Nagler","year":"2023","journal-title":"Bone Marrow Transpl"},{"issue":"11","key":"2026082510524527100_bib5","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(19)30158-9","article-title":"Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis","volume":"6","author":"Shouval","year":"2019","journal-title":"Lancet Haematol"},{"issue":"11","key":"2026082510524527100_bib6","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/bloodadvances.2023012385","article-title":"Racial\/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation","volume":"8","author":"Fingrut","year":"2024","journal-title":"Blood Adv"},{"issue":"3","key":"2026082510524527100_bib7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/bmt.2012.150","article-title":"Race\/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization","volume":"48","author":"Pidala","year":"2013","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"2026082510524527100_bib8","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2012.44.3523","article-title":"T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation","volume":"31","author":"Bashey","year":"2013","journal-title":"J Clin Oncol"},{"issue":"8","key":"2026082510524527100_bib9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with post-transplant cyclophosphamide versus matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2026082510524527100_bib10","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1182\/blood-2015-09-671834","article-title":"Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors","volume":"127","author":"Kanate","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2026082510524527100_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3324\/haematol.2013.094193","article-title":"Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors","volume":"99","author":"Marks","year":"2014","journal-title":"Haematologica"},{"issue":"28","key":"2026082510524527100_bib12","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1200\/JCO.24.00184","article-title":"Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis attenuates disparity in outcomes between use of matched or mismatched unrelated donors","volume":"42","author":"Shaffer","year":"2024","journal-title":"J Clin Oncol"},{"issue":"10","key":"2026082510524527100_bib13","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1182\/bloodadvances.2020001554","article-title":"Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant","volume":"4","author":"Sharma","year":"2020","journal-title":"Blood Adv"},{"issue":"31","key":"2026082510524527100_bib14","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1200\/JCO-25-00206","article-title":"Primary results from BMT CTN 1702 - clinical transplant-related long-term outcomes of alternative donor allogeneic transplantation (CTRL-ALT-D)","volume":"43","author":"Lee","year":"2025","journal-title":"J Clin Oncol"},{"issue":"3","key":"2026082510524527100_bib15","first-page":"346","article-title":"Access to allogeneic cell transplantation based on donor search prognosis: BMT CTN 1702 trial","volume":"32","author":"Dehn","year":"2025","journal-title":"Transpl Cell Ther"},{"issue":"31","key":"2026082510524527100_bib16","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1200\/JCO-25-00206","article-title":"Primary results from blood and marrow transplant clinical trials network 1702: clinical transplant-related long-term outcomes of alternative donor allogeneic transplantation","volume":"43","author":"Lee","year":"2025","journal-title":"J Clin Oncol"},{"issue":"25","key":"2026082510524527100_bib17","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bolanos-Meade","year":"2023","journal-title":"N Engl J Med"},{"issue":"9577","key":"2026082510524527100_bib18","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)60915-5","article-title":"Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study","volume":"369","author":"Eapen","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"2026082510524527100_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbmt.2006.11.005","article-title":"A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients","volume":"13","author":"Hwang","year":"2007","journal-title":"Biol Blood Marrow Transpl"},{"issue":"12","key":"2026082510524527100_bib20","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/ajh.27466","article-title":"Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"99","author":"Baron","year":"2024","journal-title":"Am J Hematol"},{"issue":"2","key":"2026082510524527100_bib21","first-page":"103.e1","article-title":"Comparison of nonrelapse mortality after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide versus single umbilical cord blood transplantation in hematologic disease","volume":"31","author":"Harada","year":"2025","journal-title":"Transpl Cell Ther"},{"issue":"5","key":"2026082510524527100_bib22","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/bjh.19372","article-title":"First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia","volume":"204","author":"Jo","year":"2024","journal-title":"Br J Haematol"},{"key":"2026082510524527100_bib23","doi-asserted-by":"crossref","first-page":"963689720964771","DOI":"10.1177\/0963689720964771","article-title":"Haploidentical hematopoietic stem cell transplantation versus umbilical cord blood transplantation in hematologic malignancies: a systematic review and meta-analysis","volume":"29","author":"Wu","year":"2020","journal-title":"Cell Transpl"},{"issue":"3","key":"2026082510524527100_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood.2020007535","article-title":"Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial","volume":"137","author":"Fuchs","year":"2021","journal-title":"Blood"},{"issue":"2","key":"2026082510524527100_bib25","first-page":"109.e101","article-title":"Umbilical cord blood or HLA-haploidentical transplantation: real-world outcomes versus randomized trial outcomes","volume":"28","author":"O'Donnell","year":"2022","journal-title":"Transpl Cell Ther"},{"issue":"7","key":"2026082510524527100_bib26","first-page":"406.e401","article-title":"Impact of center experience with donor type on outcomes: a secondary analysis, blood and marrow transplant clinical trials network 1101 open for accrual June 2012 open for accrual June 2012","volume":"28","author":"Brunstein","year":"2022","journal-title":"Transpl Cell Ther"},{"issue":"3","key":"2026082510524527100_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.2021011281","article-title":"HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis","volume":"138","author":"Gooptu","year":"2021","journal-title":"Blood"},{"issue":"7","key":"2026082510524527100_bib28","first-page":"395.e1","article-title":"Haploidentical versus matched unrelated versus matched sibling donor hematopoietic cell transplantation with post-transplantation cyclophosphamide","volume":"28","author":"Mehta","year":"2022","journal-title":"Transpl Cell Ther"},{"issue":"3","key":"2026082510524527100_bib29","first-page":"184.e1","article-title":"Haploidentical versus matched unrelated donor transplants using post-transplantation cyclophosphamide for lymphomas","volume":"29","author":"Mussetti","year":"2023","journal-title":"Transpl Cell Ther"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/16\/5543\/2537622\/blooda_adv-2026-020355-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/16\/5543\/2537622\/blooda_adv-2026-020355-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:59:06Z","timestamp":1787669946000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/16\/5543\/568887\/Donor-specific-transplant-outcomes-from-BMT-CTN"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":29,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026,8,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026020355","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,25]]},"published":{"date-parts":[[2026,8,13]]}}}